Goldman Sachs logo
Goldman Sachs

May 13, 2026

Shionogi Earnings Review Sales Solid But Profits Miss Expectations

Single Stock ReportEquitiesHealth Care

Shionogi reported FY3/26 results that missed profit expectations due to high investment costs, resulting in a maintained Neutral rating and ¥3,300 target price.

Key Takeaways

  • 1.FY3/26 operating profits of ¥166.7 bn missed GSe of ¥186.4 bn due to higher SG&A costs and impairment losses on pipeline products.
  • 2.FY3/27 operating profit guidance of ¥220 bn is below previous estimates, primarily due to increased R&D and edaravone inventory costs.
  • 3.The Neutral rating is maintained as the current share price offers little valuation appeal, with future growth dependent on HIV pipeline and JT synergies.

Table of Contents

  • Results overview and GSe revisions
  • Price Target Risks and Methodology - Shionogi & Co.
  • Investment Thesis - Shionogi & Co.
  • Disclosure Appendix

Document Preview

Page 1 of 5
Page 1 of Shionogi Earnings Review Sales Solid But Profits Miss Expectations
Subscribe for full access

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.